NAD+ in a serum: the molecule, the shelf, the epidermis

NAD+ is a coenzyme with a job description, and the job is older than the category printed under it. Cells use it to shuttle electrons, to feed the respiratory chain, and as the substrate sirtuins consume when they strip acetyl groups off proteins. Tissue levels fall with age. Oral precursors turned that fact into a market: nicotinamide mononucleotide, NMN, and nicotinamide riboside, NR. The same abbreviations now sit on serums in formulation buying at the Kosmetikfachhandel in Munich. A treatment room already knows why the coenzyme matters. It needs to know whether the molecule in the bottle is still the molecule on the label, and whether living epidermis ever meets it.

NAD+ itself is polar, phosphorylated and a poor passenger across the stratum corneum. Surface hydrolysis takes it apart before a fibroblast is invited. A jar that says NAD+ often contains a precursor, a derivative, or a quantity below any plausible effect. Chromatography settles that argument. Typography hopes you will not ask.

Precursors die in warm light

NMN and NR are smaller than NAD+ and, taken by mouth, are studied as ways to refill cellular synthesis. On skin the balance sheet changes. Both are sensitive to hydrolysis. A high pH, a warm shelf, an open jar after the third client: the precursor becomes nicotinamide, or fragments that no longer match the drawing in the brochure. Nicotinamide, the cosmetic niacinamide, is a legitimate raw material. It supports barrier lipids and appears in work on keratinocyte NAD+ supply. It remains a different molecule from NMN. A clinic that swaps the names because both start with nicotin- is renaming the treatment in the chart.

Cabin practice follows from the chemistry. Airless packs. A cold chain if the maker specifies one. A period-after-opening shorter than the body lotion beside it. In trade buying, ask for the stability curve: content at time zero and at three months, at 25 C and at 40 C. With no curve, the number on the acrylic display is an intention wearing a percentage.

Sirtuins, SIRT1 most often in skin papers, couple their turnover to NAD+. When the coenzyme drops, deacetylation of target proteins drops with it, including regulators tied to inflammatory tone and DNA repair pathways. That is cell biology you can explain in one breath. A topical system can, at best, improve local precursor supply, and only if the molecule reaches living epidermis. The serum does not reprogram a face because the enzyme exists.

Liposomes, a pH window, and the dose that counts

Lipid vesicles are the honest answer to a polar solute. A liposome can hold NMN or NR inside a bilayer that can negotiate with stratum corneum lipids. Size, charge and cholesterol decide whether the vesicle stalls in the outer layers or falls apart deeper. Giant multilamellar cartoons on a brochure graphic are illustration. Epidermal delivery cares more about vesicles on the order of 100 to 200 nanometres, a measured load, and a pH that does not split the precursor on contact. Working windows are mildly acidic, often around pH 5 to pH 6, close to skin and kinder to many NAD+ precursors. The manufacturer states the number. The sales script improvises it.

A liposome is a container. If the carton says NAD+ and the assay says nicotinamide, the vesicle delivered a different molecule.

Oral study doses, often hundreds of milligrams a day, have nothing to do with one millilitre of serum. A serious topical declares percent or milligrams per millilitre and shows how much is recovered in a skin model after a realistic leave-on time. With that figure, a clinic can compare: niacinamide at 5 percent, dull and formulable, against an NMN liposome carrying far less payload at a higher price. Sometimes the dull molecule wins. The menu is allowed to say so, out loud, in the same sentence as the price.

• NAD+ is polar and hydrolysis-prone. Intact stratum corneum barely lets it through as the coenzyme.
• NMN and NR are precursors. Wrong pH, heat and air take them apart before a sirtuin is involved.
• Niacinamide is the stable, cosmetically documented relative. Selling it as NMN mislabels the bottle.
• Liposomes change distribution when load, size and pH window are assayed. A drawing of a sphere does not.
• SIRT1 uses NAD+ as substrate. A serum that names the enzyme has still to show a clinical effect worth the word longevity.

What a room may say about sirtuins

Sirtuins are enzymes. You add glycerin to a cream. You do not add an enzyme the same way and expect it to switch youth back on. A claim that the cream contains sirtuins and therefore restarts a clock mixes the enzyme with its substrate. Cosmetic language can talk about comfort, look, and support for skin that gets drier and slower to recover with age. Resetting an epigenetic clock asks for an assay and a legal status the room does not have.

In professional beauty retail, read the INCI order before you read the mood board. If nicotinamide sits near the top and NMN or an NAD derivative sits in the trace zone, the formula is a niacinamide serum in a longevity jacket. It may be a good serum. Name it for what the list already confessed. Ask for encapsulation efficiency: free versus entrapped NMN, measured. Ask whether the vesicle survives being stirred into the cream base. Some liposomes die in the kettle and leave a pretty word on the carton.

Pairing is the operational trap. Acids that drop skin pH for an hour can stress an acid-labile precursor or, depending on the formula, increase penetration. Both are possible. Both have to be tested for that exact pair. A room that applies a PHA fluid in the morning and an NMN liposome at night needs the release in writing. A tip muttered with the supplier is how lots get blamed for a protocol nobody wrote down.

A buying sequence you can run twice

A usable NAD+ offer is short on theatre. Photoprotection in the morning, because UV drives NAD+ consumption in keratinocytes and every topical strategy without it pours into a leak. The precursor at night on quiet skin. Freshly peeled skin only if the formula was built for a disrupted barrier and says so on the release. Airless pumps stay at the station. tester bottles left open on a windowsill since yesterday say nothing about the lot in your stockroom.

The chart note stays thin. Product, lot, pH from the data sheet, whether a liposome is declared, skin response at 48 hours on first use. Leave sirtuin activity off the promise list. Leave cellular energy off the before-and-after card. Energy in the cell is ATP. NAD+ participates in making it. A sentence that swaps the two has skipped the biochemistry, or hopes the client will.

Supplier shelves will be dense this season with precursors, vesicles and sirtuin peptides that mimic an enzyme while remaining chemically distant from NAD+. Sort by assay. If chromatography fails to show intact NMN, NR or a clearly named derivative, you are holding a different product with a fashionable abbreviation. Skin absorbs what arrives. The rest is type on a pump.